Does the Time to Start First-Line Treatment Influence the Survival of Favorable-Risk Patients With Metastatic Renal Cell Carcinoma? Results of the MetaSurv–UroCCR 79 Study
Titel:
Does the Time to Start First-Line Treatment Influence the Survival of Favorable-Risk Patients With Metastatic Renal Cell Carcinoma? Results of the MetaSurv–UroCCR 79 Study
Auteur:
Rolley, Cyrielle Barthelemy, Philippe Bensalah, Karim Nouhaud, François-Xavier Villers, Arnauld Bruyère, Franck Lebdai, Souhil Ricard, Solène Gross-Goupil, Marine Rouprêt, Morgan Bernhard, Jean-Christophe Bigot, Pierre